Casodex Related Clinical Trials
Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX [Completed]
Casodex - Nolvadex Combination [Completed]
Casodex 150-mg Compassionate Use Trial for Subjects With Prostate Cancer [No longer available]
Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer [Recruiting]
Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy [Recruiting]
CP-675,206 in Combination With Short Term Androgen Deprivation in Patients With Stage D0 Prostate Cancer [Recruiting]
Bicalutamide (Casodexâ„¢) Versus Placebo in Patients With Early Prostate Cancer [Active, not recruiting]
Phase II Trial: Higher Dose Casodex in Hormone Refractory Prostate Cancer Patients. [Recruiting]
Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer [Recruiting]
Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer. [Recruiting]
(Bicalutamide) Casodex vs Placebo in Non-Metastatic Early Prostate Cancer [Active, not recruiting]
Bioequivalence of ICI176,334-1 in Japanese Healthy Male Subjects [Not yet recruiting]
Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy [Completed]
Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer [Recruiting]
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer [Recruiting]
Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer [Not yet recruiting]
Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 Mg in Patients With Prostate Cancer [Active, not recruiting]
Casodex/Zoladex Biomarkers in Localised Prostate Cancer [Completed]
Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis] [Active, not recruiting]
Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg [Recruiting]
Casodex vs Placebo in Non-Metastatic Early Prostate Cancer [Active, not recruiting]
Pazopanib With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy [Recruiting]
Combination Casodex® and Iressaâ„¢ in Locally Advanced Prostate Cancer [Completed]
Open Label,Phase II Trial of MAB Dose Escalation OF Bicalutamide For Biochemical Failure In Prostate Cancer Patients. [Recruiting]
Effect of Casodex on Tumour Hypoxia - Prostate Cancer [Recruiting]
Efficacy and Safety of Zactimaâ„¢ in Patients With Castration-Refractory Metastatic Prostate Cancer [Recruiting]
Bicalutamide in Treating Patients With Metastatic Breast Cancer [Recruiting]
Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer [Completed]
Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer [Recruiting]
RAD001 and Bicalutamide for Androgen Independent Prostate Cancer [Recruiting]
Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide [Recruiting]
Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer [Active, not recruiting]
Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer [Active, not recruiting]
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration [Recruiting]
Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer [Recruiting]
TAK-700 in Castration Resistant Prostate Cancer [Not yet recruiting]
Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum [Active, not recruiting]
Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer [Recruiting]
Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer [Recruiting]
Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer [Recruiting]
Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic T2-T3N0 Prostate Cancer [Recruiting]
Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer [Recruiting]
External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer [Recruiting]
Degarelix Neo-Adjuvant Radical Prostatectomy Trial [Recruiting]
Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer [Recruiting]
Bicalutamide and Deforolimus in Men With Prostate Cancer [Recruiting]
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer [Active, not recruiting]
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer [Active, not recruiting]
Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy [Active, not recruiting]
Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients [Recruiting]
A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer [Not yet recruiting]
Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy [Recruiting]
Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide [Completed]
Survival Outcomes and Tumor Molecular Profile Following Bicalutamide Neoadjuvant Therapy [Completed]
Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancer [Recruiting]
CMAB vs IMAB in Metastatic Prostate Cancer [Withdrawn]
Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or Not [Active, not recruiting]
Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer [Recruiting]
Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA [Recruiting]
Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer [Recruiting]
Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment [Active, not recruiting]
Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer [Not yet recruiting]
Changes in Bone Mineral Density and Fracture Risk in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer [Completed]
Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle [Active, not recruiting]
Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer [Recruiting]
Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Avastin, Docetaxel and Androgen Deprivation Followed by Continued Avastin and Androgen Deprivation for Men With a Rising PSA After Local Therapy [Recruiting]
Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer [Recruiting]
Radiation Therapy and Androgen Deprivation Therapy in Treating Patients Who Have Undergone Surgery for Prostate Cancer (RADICALS) [Recruiting]
CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer [Completed]
SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer [Terminated]
Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Intensity-Modulated Radiation Therapy, Docetaxel, and Hormone Therapy in Treating Patients With High-Risk Locally Advanced Prostate Cancer With Pelvic Lymph Node Metastasis
Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy [Active, not recruiting]
Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer [Completed]
Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer [Active, not recruiting]
Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer [Completed]
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse [Recruiting]
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer [Recruiting]
Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer [Recruiting]
Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Androgen Deprivation Therapy for Metastatic Prostate Cancer [Recruiting]
Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer [Recruiting]
Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer [Recruiting]
Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy [Recruiting]
Androgen Suppression Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With High-Risk Localized Prostate Cancer [Recruiting]
Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy [Recruiting]
Hormone Therapy in Treating Patients With Advanced Prostate Cancer [Active, not recruiting]
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer [Withdrawn]
Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer [Active, not recruiting]
Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer [Active, not recruiting]
Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial [Recruiting]
Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNts [Recruiting]
Hormone Therapy in Treating Men With Stage IV Prostate Cancer [Recruiting]
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy [Recruiting]
The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men With Prostate Cancer Age 65 and Older [Recruiting]
A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Subjects With a Rising PSA [Recruiting]
Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer [Recruiting]
|
